The CMS CY 2026 Final Rule introduced new requirements for pharmacies billing for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), increasing oversight and adding new operational considerations.
ACHC published FAQs to explain the changes for infusion (IRX, IRX-NO797), specialty (SRX), and long-term care pharmacies (LTC) that seek accreditation to bill for products categorized as DMEPOS.
The list below includes the most common DMEPOS products billed for pharmacy patients:
- External infusion pumps (DM12)
- External infusion pump supplies (DM24)
- Enteral nutrients and related equipment and supplies (PE03, 04)
- Parenteral nutrients and related equipment and supplies (PE05, 06)
- Nebulizer and supplies (R07)
- Glucose Meters and Supplies (DM05,06) Read more >
